Russell Investments Group
ITCI

Russell Investments Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Russell Investments Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,336
Closed -$1.1M – 3996
2025
Q1 		$1.1M Sell
8,336
-23,970
-74% -$2.99M ﹤0.01% 1990
2024
Q4 		$2.7M Sell
32,306
-21,017
-39% -$1.73M ﹤0.01% 1505
2024
Q3 		$3.9M Sell
53,323
-16,415
-24% -$1.23M 0.01% 1323
2024
Q2 		$4.78M Buy
69,738
+18,893
+37% +$1.31M 0.01% 1175
2024
Q1 		$3.52M Buy
50,845
+35,528
+232% +$2.44M 0.01% 1324
2023
Q4 		$1.1M Buy
15,317
+7,572
+98% +$436K ﹤0.01% 1919
2023
Q3 		$403K Sell
7,745
-8
-0.1% -$466 ﹤0.01% 2295
2023
Q2 		$491K Buy
7,753
+3,911
+102% +$244K ﹤0.01% 2225
2023
Q1 		$208K Buy
3,842
+42
+1% +$2.03K ﹤0.01% 2468
2022
Q4 		$201K Hold
3,800
– – ﹤0.01% 2565
2022
Q3 		$176K Sell
3,800
-105,073
-97% -$5.49M ﹤0.01% 2572
2022
Q2 		$6.21M Sell
108,873
-335,502
-75% -$19M 0.01% 981
2022
Q1 		$27.2M Buy
444,375
+61,756
+16% +$3.21M 0.05% 466
2021
Q4 		$20M Sell
382,619
-15,870
-4% -$667K 0.03% 607
2021
Q3 		$14.9M Buy
398,489
+126,168
+46% +$4.39M 0.03% 712
2021
Q2 		$11.1M Buy
272,321
+262,787
+2,756% +$9.71M 0.02% 878
2021
Q1 		$323K Buy
+9,534
New +$331K ﹤0.01% 2686
2020
Q4 		– Sell
-7,245
Closed -$185K – 3218
2020
Q3 		$185K Hold
7,245
– – ﹤0.01% 2797
2020
Q2 		$185K Buy
+7,245
New +$147K ﹤0.01% 2730
2020
Q1 		– Sell
-57,972
Closed -$1.99M – 3162
2019
Q4 		$1.99M Buy
57,972
+25,971
+81% +$312K ﹤0.01% 1740
2019
Q3 		$239K Buy
32,001
+14,301
+81% +$137K ﹤0.01% 2540
2019
Q2 		$230K Buy
17,700
+6,600
+59% +$84.6K ﹤0.01% 2483
2019
Q1 		$135K Buy
11,100
+7,000
+171% +$89.4K ﹤0.01% 2685
2018
Q4 		$47K Buy
+4,100
New +$66.2K ﹤0.01% 2804
2018
Q1 		– Sell
-6,200
Closed -$94K – 3020
2017
Q4 		$94K Sell
6,200
-200
-3% -$3.09K ﹤0.01% 2789
2017
Q3 		$101K Buy
+6,400
New +$93.9K ﹤0.01% 2772
2017
Q2 		– Sell
-38,357
Closed -$623K – 3052
2017
Q1 		$623K Buy
38,357
+1,402
+4% +$20.3K ﹤0.01% 2335
2016
Q4 		$574K Buy
+36,955
New +$522K ﹤0.01% 2416

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's ITCI Position: Q2 2025 in Review

Russell Investments Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 8,336 shares — an estimated $1.1M sold.

Russell Investments Group first reported a position in ITCI in Q4 2016 and held it in 28 quarters. The position peaked at $27.2M in Q1 2022. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Russell Investments Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 8,336 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.1M.
  • Russell Investments Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2016 and held it in 28 quarters.
  • Russell Investments Group's Intra-Cellular Therapies Inc. position peaked at $27.2M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.